Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier:
NCT01401374
First received: July 21, 2011
Last updated: May 13, 2014
Last verified: March 2011
  Purpose

The study is an on-line survey posted on survey monkey that addresses some demographic and environmental issues that could potentially relate to vitiligo vulgaris onset or disease exacerbation.


Condition
Vitiligo Vulgaris

Study Type: Observational
Official Title: Online Health Survey of Patients With Vitiligo Vulgaris/ Online Survey of Pediatric Patients With Vitiligo

Resource links provided by NLM:


Further study details as provided by St. Luke's-Roosevelt Hospital Center:

Primary Outcome Measures:
  • Correlation of Disease State in Vitiligo with Clinical and Psychological Measures [ Time Frame: Self-reported retrospective single survey ] [ Designated as safety issue: No ]

Estimated Enrollment: 1500
Study Start Date: March 2011
Estimated Study Completion Date: March 2015
Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
Groups/Cohorts
Vitiligo Patients
patients with vitiligo vulgaris
Controls
Individuals without vitiligo vulgaris

Detailed Description:

The survey is designed to look at some issues that are pertinent to individuals with vitiligo, including access to care, severity of disease, under-reported disease activity, causative and exacerbating factors and co-morbid illnesses.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Individuals self-reporting vitiligo vulgaris and controls who do not have vitiligo vulgaris

Criteria

Inclusion Criteria:

  • Ability to complete survey

Exclusion Criteria:

  • Inability to complete survey
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01401374

Locations
United States, New York
St. Luke's-Roosevelt Hospital Center
New york, New York, United States, 10025
Sponsors and Collaborators
St. Luke's-Roosevelt Hospital Center
Investigators
Principal Investigator: Nanette Silverberg, MD St. Luke's-Roosevelt Hospital Center
  More Information

No publications provided by St. Luke's-Roosevelt Hospital Center

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: St. Luke's-Roosevelt Hospital Center
ClinicalTrials.gov Identifier: NCT01401374     History of Changes
Other Study ID Numbers: 10-148/10-149x
Study First Received: July 21, 2011
Last Updated: May 13, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by St. Luke's-Roosevelt Hospital Center:
Vitiligo Vulgaris
Autoimmunity
Thyroid Disease

Additional relevant MeSH terms:
Vitiligo
Hypopigmentation
Pigmentation Disorders
Skin Diseases

ClinicalTrials.gov processed this record on November 25, 2014